University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, 60637, United States
NCT Number: NCT00000251
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To evaluate the acute and residual effects of subanesthetic concentrations of isoflurane/nitrous oxide combinations in healthy volunteers.
Looking for future studies?
Notify Me21 year–32 year
All sexes
Interventional
Phase 2
Chicago, Illinois, 60637, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Please contact site for information.
Placebo
Time frame: 15 & 30 min inhalation and 5, 30, & 60 min post inhalation
Time frame: 15 & 30 min inhalation and 5, 30, & 60 min post inhalation
Time frame: 15 & 30 min inhalation and 5,30 & 60 min post inhalation
Time frame: 2,15 & 30 min inhalation and 5,30 & 60 min post inhalation
University of Chicago
Other
Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06023459
Chemically-Induced Disorders, Mental Disorders
El Dorado, Arkansas, United States
View Trial DetailsNCT04567784
Chemically-Induced Disorders, Heroin Abuse
New York, United States
View Trial DetailsNCT04235582
Behavior, Behavior Therapy
Berkeley, California, United States
View Trial DetailsNCT00000319
Chemically-Induced Disorders, Mental Disorders
New Haven, Connecticut, United States
View Trial Details